Bavarian Nordic A/S 0DPB.IL Stock
Bavarian Nordic A/S Price Chart
Bavarian Nordic A/S 0DPB.IL Financial and Trading Overview
Bavarian Nordic A/S stock price | 155.92 DKK |
Previous Close | 213.2 DKK |
Open | 214.8 DKK |
Bid | 207.2 DKK x N/A |
Ask | 217.8 DKK x N/A |
Day's Range | 212.1 - 216.1 DKK |
52 Week Range | 171.45 - 410.7 DKK |
Volume | 2.64K DKK |
Avg. Volume | 46.32K DKK |
Market Cap | 16.53B DKK |
Beta (5Y Monthly) | 1.410344 |
PE Ratio (TTM) | 48.850574 |
EPS (TTM) | 14.09 DKK |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
0DPB.IL Valuation Measures
Enterprise Value | 13.11B DKK |
Trailing P/E | 48.850574 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 4.0476384 |
Price/Book (mrq) | 1.7193391 |
Enterprise Value/Revenue | 3.212 |
Enterprise Value/EBITDA | 15.257 |
Trading Information
Bavarian Nordic A/S Stock Price History
Beta (5Y Monthly) | 1.410344 |
52-Week Change | 3.40% |
S&P500 52-Week Change | 20.43% |
52 Week High | 410.7 DKK |
52 Week Low | 171.45 DKK |
50-Day Moving Average | 196.07 DKK |
200-Day Moving Average | 217.63 DKK |
0DPB.IL Share Statistics
Avg. Volume (3 month) | 46.32K DKK |
Avg. Daily Volume (10-Days) | 75.26K DKK |
Shares Outstanding | 77.77M |
Float | 73.73M |
Short Ratio | N/A |
% Held by Insiders | 0.090% |
% Held by Institutions | 30.51% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 7.37% |
Operating Margin (ttm) | 12.02% |
Gross Margin | 61.16% |
EBITDA Margin | 21.05% |
Management Effectiveness
Return on Assets (ttm) | 2.43% |
Return on Equity (ttm) | 3.70% |
Income Statement
Revenue (ttm) | 4.08B DKK |
Revenue Per Share (ttm) | 57.15 DKK |
Quarterly Revenue Growth (yoy) | 291.19% |
Gross Profit (ttm) | 1.7B DKK |
EBITDA | 859.46M DKK |
Net Income Avi to Common (ttm) | 300.93M DKK |
Diluted EPS (ttm) | 4.35 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 2.97B DKK |
Total Cash Per Share (mrq) | 40.28 DKK |
Total Debt (mrq) | 86.7M DKK |
Total Debt/Equity (mrq) | 0.95 DKK |
Current Ratio (mrq) | 2.863 |
Book Value Per Share (mrq) | 123.594 |
Cash Flow Statement
Operating Cash Flow (ttm) | -18438000 DKK |
Levered Free Cash Flow (ttm) | -1088122240 DKK |
Profile of Bavarian Nordic A/S
Country | United Kingdom |
State | N/A |
City | Hellerup |
Address | Philip Heymans Alle 3 |
ZIP | 2900 |
Phone | 45 33 26 83 83 |
Website | https://www.bavarian-nordic.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 1040 |
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name. It is also developing MVA-BN (freeze-dried) that has completed Phase III clinical trials for the treatment of smallpox; MVA-BN RSV, which is in Phase III clinical trials for the treatment of respiratory syncytial virus; ABNCoV2 that has completed Phase II clinical trial for the treatment of SARS-CoV-2; and TAEK-VAC, which is in Phase I/II clinical trial for treatment of advanced HER2 and brachyury-expressing cancers. It has license and collaboration agreement with AdaptVac; and license agreements with National Cancer Institute and Public Health Service. It operates in the United States, Germany, Belgium, France, Canada, the United Kingdom, Hong Kong, Saudi Arabia, Australia, Switzerland, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark.
Q&A For Bavarian Nordic A/S Stock
What is a current 0DPB.IL stock price?
Bavarian Nordic A/S 0DPB.IL stock price today per share is 155.92 DKK.
How to purchase Bavarian Nordic A/S stock?
You can buy 0DPB.IL shares on the IOB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bavarian Nordic A/S?
The stock symbol or ticker of Bavarian Nordic A/S is 0DPB.IL.
Which industry does the Bavarian Nordic A/S company belong to?
The Bavarian Nordic A/S industry is Biotechnology.
How many shares does Bavarian Nordic A/S have in circulation?
The max supply of Bavarian Nordic A/S shares is 93.86M.
What is Bavarian Nordic A/S Price to Earnings Ratio (PE Ratio)?
Bavarian Nordic A/S PE Ratio is 11.06616000 now.
What was Bavarian Nordic A/S earnings per share over the trailing 12 months (TTM)?
Bavarian Nordic A/S EPS is 14.09 DKK over the trailing 12 months.
Which sector does the Bavarian Nordic A/S company belong to?
The Bavarian Nordic A/S sector is Healthcare.